Financhill
Back

Acumen Pharmaceuticals Vs. Target Industry Stock Comparison

Sell
14

ABOS
Acumen Pharmaceuticals

Last Price:
2.30
Seasonality Move:
-0.29%
Sell
25

TGT
Target

Last Price:
121.00
Seasonality Move:
4.08%
Sell
14
Acumen Pharmaceuticals (ABOS) is a Sell

Is Acumen Pharmaceuticals a Buy, Sell or Hold?

  • The current Acumen Pharmaceuticals [ABOS] share price is $2.37. The Score for ABOS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • ABOS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
25
Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

  • The current Target [TGT] share price is $121.72. The Score for TGT is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • TGT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABOS Stock Price Chart

What is Acumen Pharmaceuticals's stock price today?

  • The Acumen Pharmaceuticals share price today is $2.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABOS is experiencing slight selling pressure.

TGT Stock Price Chart

What is Target's stock price today?

  • The Target share price today is $121.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing selling pressure, which indicates risk of future bearish movement.

ABOS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 40.25 Sell
Chaikin Money Flow: -41653 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.51 - 3.07) Sell
Bollinger Bands (100): (2.36 - 3.02) Sell

TGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.84 Sell
Relative Strength Index (14 RSI): 23.97 Sell
Chaikin Money Flow: -42314401 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (143.94 - 157.22) Sell
Bollinger Bands (100): (143.14 - 156.64) Sell

ABOS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.56 Sell
20-day SMA: 2.81 Sell
50-day SMA: 2.61 Sell
200-day SMA: 3.06 Sell
8-day EMA: 2.53 Sell
20-day EMA: 2.67 Sell
50-day EMA: 2.68 Sell
200-day EMA: 3.04 Sell

TGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 150.48 Sell
20-day SMA: 150.04 Sell
50-day SMA: 152.15 Sell
200-day SMA: 153.96 Sell
8-day EMA: 146.85 Sell
20-day EMA: 149.85 Sell
50-day EMA: 150.95 Sell
200-day EMA: 149.91 Sell

Acumen Pharmaceuticals Earnings Growth & ABOS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and a decrease next year of $0.04 per share.

Target Earnings Growth & TGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.81 per share, and an increase next year of $0.95 per share.

Acumen Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Target Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):